Literature DB >> 13129922

Cooperative roles of Fyn and cortactin in cell migration of metastatic murine melanoma.

Jinhong Huang1, Tamae Asawa, Tsuyoshi Takato, Ryuichi Sakai.   

Abstract

Src family kinases are major regulators of various integrin-mediated biological processes, although their functional roles and substrates in cancer metastasis are unknown. We explored the roles of Src family tyrosine kinases in cell migration and the spread of K-1735 murine melanoma cell lines with low or high metastatic potential. Corresponding to elevated cell motility and spreading ability, Fyn was selectively activated among Src family kinases, and the cell motility was blocked by an inhibitor of Src family kinases. Significant tyrosine phosphorylation of cortactin, stable complex formation between activated Fyn and cortactin, and co-localization of cortactin with Fyn at cell membranes were all observed only in cells with high metastatic potential. Both integrin-mediated Fyn activation and hyperphosphorylation of cortactin were observed 2-5 h after stimulation in highly metastatic cells, and they required de novo protein synthesis. We demonstrate that cortactin is a specific substrate and cooperative effector of Fyn in integrin-mediated signaling processes regulating metastatic potential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129922     DOI: 10.1074/jbc.M308213200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Src family kinases are involved in EphA receptor-mediated retinal axon guidance.

Authors:  Bernd Knöll; Uwe Drescher
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

2.  Src tyrosyl phosphorylates cortactin in response to prolactin.

Authors:  Alan Hammer; Sneha Laghate; Maria Diakonova
Journal:  Biochem Biophys Res Commun       Date:  2015-06-01       Impact factor: 3.575

3.  ADAMTS-4 and biglycan are expressed at high levels and co-localize to podosomes during endothelial cell tubulogenesis in vitro.

Authors:  Masanari Obika; Robert B Vernon; Michel D Gooden; Kathleen R Braun; Christina K Chan; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2013-09-18       Impact factor: 2.479

4.  Src binds cortactin through an SH2 domain cystine-mediated linkage.

Authors:  Jason V Evans; Amanda G Ammer; John E Jett; Chris A Bolcato; Jason C Breaux; Karen H Martin; Mark V Culp; Peter M Gannett; Scott A Weed
Journal:  J Cell Sci       Date:  2012-10-24       Impact factor: 5.285

5.  Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence.

Authors:  Laura C Kelley; Karen E Hayes; Amanda Gatesman Ammer; Karen H Martin; Scott A Weed
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

6.  Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway.

Authors:  Yorihisha Imanishi; Bo Hu; Michael J Jarzynka; Ping Guo; Esther Elishaev; Ifat Bar-Joseph; Shi-Yuan Cheng
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

7.  Involvement of cortactin and phosphotyrosine proteins in cell-cell contact formation in cultured bovine corneal endothelial cells.

Authors:  Lily Kredy-Farhan; Shlomo Kotev-Emeth; Naphtali Savion
Journal:  Histochem Cell Biol       Date:  2007-11-14       Impact factor: 4.304

Review 8.  Contactin 1: A potential therapeutic target and biomarker in gastric cancer.

Authors:  De-Hu Chen; Ji-Wei Yu; Bo-Jian Jiang
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

Review 9.  Cortactin branches out: roles in regulating protrusive actin dynamics.

Authors:  Amanda Gatesman Ammer; Scott A Weed
Journal:  Cell Motil Cytoskeleton       Date:  2008-09

10.  Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression.

Authors:  Xu-Zhi Xu; Marileila Varella Garcia; Tian-yu Li; Li-Yan Khor; R Sujatha Gajapathy; Cindy Spittle; Scott Weed; Stuart R Lessin; Hong Wu
Journal:  Mod Pathol       Date:  2009-11-06       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.